ArticleFrontiers in pharmacology2024

Optimising infliximab induction dosing to achieve clinical remission in Chinese patients with Crohn's disease.

Kouzhu Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.